The GLP-1 Strategy: Ozempic, Wegovy, and Mounjaro Done Right

TL;DR: GLP-1 medications are powerful, but the script is the easy part. The hard part is keeping your muscle, getting enough protein, managing side effects, and planning when to come off. At Fishtown Medicine, we build the full chassis around the engine, not just hand you the keys.

Why GLP-1 Medications Are a Big Deal

If you live in Philadelphia, you know someone on Ozempic, Wegovy, Zepbound, or Mounjaro. These are GLP-1 receptor agonists, a class of medications that mimic a gut hormone called GLP-1. They are not "cheating." They correct deep signaling errors in the brain and gut that drive hunger and metabolic dysfunction. But there is a problem. Most prescribers treat GLP-1 medications like a light switch. Turn it on, lose weight. They write the script, pat you on the back, and send you home. That is not where the story should end. Rapid weight loss without a strategy can lead to sarcopenia (muscle loss), metabolic slowdown, "Ozempic face," and a real loss of long-term vitality. We do this differently.

What Is the Muscle Math?

When you lose weight rapidly, 20% to 40% of that weight can come from muscle. That is a disaster for long-term health.

• Muscle is the largest glucose-disposal site in your body. It burns sugar at rest.
• Muscle protects bones from fractures.
• Higher muscle mass correlates with longer life expectancy.

If you lose 20 pounds of fat but also 10 pounds of muscle, you have technically improved your weight, but you may have worsened your long-term metabolic health and physical resilience.

What Is the Fishtown GLP-1 Strategy?

We follow the principles of Medicine 3.0. We use medications as tools, not as crutches. Our protocol has four parts.

1. Resistance Training Is Non-Negotiable

We require patients on GLP-1 medications to commit to resistance training, ideally 2 to 3 days per week. You must signal your body to keep its muscle. We help design a Zone 2 cardio and strength plan, or we connect you with local Philly trainers who understand the strategy.

2. The Protein Prescription

Your appetite will vanish on a GLP-1 medication. That means your protein intake will crash unless you plan ahead. We track protein closely. We typically target 1 gram per pound of ideal body weight per day. If solid food becomes hard, we use whey isolate or essential amino acid powders. You cannot build a body without bricks.

3. The Side Effect Plan

Nausea, constipation, fatigue, reflux, gallbladder pain. These are not "the price of weight loss." They are usually signs of dose mismatch or fast titration. Because we are a Direct Primary Care practice, you can text us: "Hey Dr. Ash, feeling nauseous today." We adjust the same day, not at your next 3-month visit.

4. The Exit Strategy

Do you want to be on this medication forever? Maybe you do, and that is clinically valid. But most patients want an off-ramp. We plan the exit on day one. By building muscle and metabolic flexibility while you are on the medication, your body can defend its new set point. We taper the dose over months, not abruptly, and we keep tracking labs and body composition long after the script ends.

Guidance from the Clinic

"We are not just treating a number on a scale. We are treating your future physical independence. If you lose weight but lose the ability to lift a bag of groceries or carry a grandchild, we have failed. In Medicine 3.0, we build the chassis first, then we tune the engine."

A common question I hear: "Will I gain it all back when I stop?" My honest answer: most patients regain about 30% to 50% of what was lost in the first year off, on average. That number drops a lot when patients have built muscle, fixed sleep, and have a maintenance plan in place. Many of my patients hold their loss with a low maintenance dose or with metformin and lifestyle alone. Book Your Warm Invitation Call

Scientific References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. The STEP 1 trial.
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
3. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes. N Engl J Med. 2023;389(24):2221-2232. The SELECT trial.
4. Heymsfield SB, et al. Effect of Once-Weekly Semaglutide on Lean Body Mass. Diabetes Obes Metab. 2024.
5. Malhotra A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024. The SURMOUNT-OSA trial.

Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right GLP-1 plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.